Inclusion of MedTech industry in DTAB subcommittee a step in right direction: MTaI

Association has welcomed the setting up of a sub-committee by the Drugs Technical Advisory Board (DTAB) to assess the issues to proposal for amendment of MDR 2017. It has expressed its commitment to work with DTAB sub-panel to frame a suitable provision


New Delhi: Medical Technology Association of India (MTaI) has called the formulation of DTAB sub-committee to examine proposal for inclusion of compensation in the policy framework on medical devices a step in the right direction.

Drugs Technical Advisory Board (DTAB), a panel under the Union Health Ministry, has decided to set up a sub-committee to assess the issues related to proposal for amendment of MDR 2017 to include provisions for compensation in case of injury or death due to malfunctioning of medical devices or if the devices are found unsafe or non-compliant with the conditions of license.

The committee is headed by Principal Consultant in Directorate General of Health Services (DGHS), Dr B D Athani and has representatives of the government, AIIMS and Safdarjung Hospitals, Medical devices industry, and consumers.

“The inclusion of Medical Device industry in the subcommittee is a positive step towards having a well-rounded decision on the proposal for inclusion of compensation in the Medical Device Rules. We will work with the expert panel to form a suitable framework on compensation, keeping in mind the interest of the stakeholders,” MTaI Chairman and Director General Mr Pavan Choudary said.

Mr Choudary is one of the representatives of Medical Devices industry in the sub-committee.